SG30654G - Antitumor antibiotic kedarcidin - Google Patents

Antitumor antibiotic kedarcidin

Info

Publication number
SG30654G
SG30654G SG1995907457A SG1995907457A SG30654G SG 30654 G SG30654 G SG 30654G SG 1995907457 A SG1995907457 A SG 1995907457A SG 1995907457 A SG1995907457 A SG 1995907457A SG 30654 G SG30654 G SG 30654G
Authority
SG
Singapore
Prior art keywords
kedarcidin
antitumor antibiotic
antibiotic kedarcidin
protein
antitumor
Prior art date
Application number
SG1995907457A
Other languages
English (en)
Inventor
Sandra June Hofstead
James Andrew Matson
Kin Sing Lam
Salvatore Forenza
James Allen Bush
Koji Tomita
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SG30654G publication Critical patent/SG30654G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
SG1995907457A 1988-04-12 1989-04-12 Antitumor antibiotic kedarcidin SG30654G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin

Publications (1)

Publication Number Publication Date
SG30654G true SG30654G (en) 1995-09-01

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995907457A SG30654G (en) 1988-04-12 1989-04-12 Antitumor antibiotic kedarcidin

Country Status (24)

Country Link
US (1) US5001112A (hu)
EP (1) EP0337430B1 (hu)
JP (1) JP2850132B2 (hu)
KR (1) KR970010137B1 (hu)
CN (1) CN1034589C (hu)
AT (1) ATE101653T1 (hu)
AU (1) AU623641B2 (hu)
CA (1) CA1338262C (hu)
CY (1) CY1849A (hu)
DE (1) DE68913063T2 (hu)
DK (1) DK174751B1 (hu)
ES (1) ES2061760T3 (hu)
FI (1) FI93969C (hu)
HK (1) HK83195A (hu)
HU (1) HU201119B (hu)
IE (1) IE62912B1 (hu)
IL (1) IL89896A0 (hu)
MY (1) MY105842A (hu)
NO (1) NO174474C (hu)
NZ (1) NZ228672A (hu)
PL (1) PL161004B1 (hu)
PT (1) PT90252B (hu)
SG (1) SG30654G (hu)
YU (1) YU73989A (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
CA2414570A1 (en) * 2002-01-24 2003-04-03 Ecopia Biosciences Inc. Method, system, and knowledge repository for identifying a secondary metabolite from a microorganism
SI2349520T1 (sl) * 2008-10-27 2016-08-31 Glaxosmithkline Biologicals S.A. Postopek čiščenja za ogljikohidrat iz Streptococcus skupine A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (hu) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
ATE101653T1 (de) 1994-03-15
FI93969C (fi) 1995-06-26
CN1037735A (zh) 1989-12-06
EP0337430A3 (en) 1991-07-24
PT90252A (pt) 1989-11-10
FI891710A (fi) 1989-10-13
NO891462D0 (no) 1989-04-10
AU623641B2 (en) 1992-05-21
HK83195A (en) 1995-06-01
PL161004B1 (pl) 1993-05-31
IL89896A0 (en) 1989-12-15
PT90252B (pt) 1994-07-29
FI93969B (fi) 1995-03-15
NZ228672A (en) 1990-07-26
FI891710A0 (fi) 1989-04-11
MY105842A (en) 1995-01-30
CY1849A (en) 1996-03-08
CN1034589C (zh) 1997-04-16
HU201119B (en) 1990-09-28
DE68913063T2 (de) 1994-06-09
CA1338262C (en) 1996-04-23
DE68913063D1 (de) 1994-03-24
NO891462L (no) 1989-10-13
IE891157L (en) 1989-10-12
EP0337430B1 (en) 1994-02-16
JPH01317396A (ja) 1989-12-22
YU73989A (en) 1991-04-30
NO174474B (no) 1994-01-31
DK174751B1 (da) 2003-10-20
NO174474C (no) 1998-06-09
PL278782A1 (en) 1989-12-27
ES2061760T3 (es) 1994-12-16
DK173589D0 (da) 1989-04-11
JP2850132B2 (ja) 1999-01-27
IE62912B1 (en) 1995-03-08
DK173589A (da) 1989-10-13
AU3272889A (en) 1989-10-19
KR900016469A (ko) 1990-11-13
EP0337430A2 (en) 1989-10-18
KR970010137B1 (ko) 1997-06-21
US5001112A (en) 1991-03-19
HUT50880A (en) 1990-03-28

Similar Documents

Publication Publication Date Title
CA2054268A1 (en) Nutritional composition
WO1989009788A3 (en) Biosynthetic osteogenic proteins and osteogenic devices containing them
AU569776B2 (en) Atrial natriuretic factors
AU625718B2 (en) Tracheobronchodilator
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE3569112D1 (en) 4,5-dihydro-4-oxo-2- û(2-trans-phenylcyclopropyl)amino¨-3-furancarboxylic acids and derivatives thereof
SG30654G (en) Antitumor antibiotic kedarcidin
EP0643133A3 (de) Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung.
CA2018461A1 (en) Novel polypeptides and their use
EP0358217A3 (en) Image reading apparatus
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
AU3810389A (en) Process for extracting and purifying epidermin
AU1719388A (en) Egg white hydrolyzate
CS473687A1 (en) Zpusob cisteni 1 amino cis 2,6 dimethylpi peridinu
AU7296487A (en) Replacing timing chains on vehicles
UA6962A (uk) Маніпулятор